3D modeling for lung segmentectomy
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether 3D models from a CT scan without dye can help guide minimally invasive lung surgery. If you have a small early-stage lung cancer and are eligible for keyhole surgery, this study might be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a small lung lesion (2 cm or smaller) that is likely or confirmed cancer.
- You have both a regular CT scan and one with contrast dye available.
- You are eligible for minimally invasive lung surgery called VATS or RATS.
- You are not allergic to CT contrast dye and have not had surgery on the same side of your chest before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses 3D models from your CT scan to help doctors predict how well your lungs will work after surgery. It is for people having a certain type of lung surgery (VATS) to remove part of a lung.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This study compares two surgical approaches for removing early-stage lung cancer (2-3 cm) from the outer part of the lung. It aims to see if removing only the affected segment (segmentectomy) is as effective as removing a larger portion of the lung (lobectomy), while potentially preserving more lung function.
This trial tests a new method using 3D virtual reality and a special dye (indocyanine green) to help surgeons see and remove only the affected part of the lung, preserving healthy tissue. It is for people with early-stage lung cancer that is small and located in one section of the lung.
This trial tests how well a computer model predicts which lymph nodes need to be removed during lung cancer surgery. If you have early-stage lung cancer that can be removed, you may be eligible.
This trial tests a new surgical technique to remove small, early-stage lung cancers that are located deep within the lung tissue. The goal is to remove only the affected area while preserving as much healthy lung as possible.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.